Skip to main content
Skip to "About government"
Language selection
Français
fr
/
Gouvernement du Canada
Search
Search Canada.ca
Search
Menu
Main
Menu
Jobs and the workplace
Immigration and citizenship
Travel and tourism
Business and industry
Benefits
Health
Taxes
Environment and natural resources
National security and defence
Culture, history and sport
Policing, justice and emergencies
Transport and infrastructure
Canada and the world
Money and finances
Science and innovation
You are here:
Canada.ca
Public Health Agency of Canada
Infectious diseases
Sexual Health and Sexually Transmitted Infections
Canadian Guidelines on Sexually Transmitted Infections
Advisories and alerts related to treatment recommendations in the Canadian Guidelines on Sexually Transmitted Infections
Quick Links
About
Levels and Quality of Evidence
Expert Working Group Membership
Table of Contents
Updates Summaries
Complementary Resources and Professional Development
Advisories and Alerts
Subscribe to receive updates/advisories
January 23, 2017
FLUOROQUINOLONES - Risk of Disabling and Persistent Serious Adverse Reactions
Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects
May 16, 2013
Zithromax/Zmax SR (azithromycin) - Risk of Potentially Fatal Irregular Heart Beats - For Health Professionals
Report a problem or mistake on this page
Please select all that apply:
A link, button or video is not working
It has a spelling mistake
Information is missing
Information is outdated or wrong
Login error when trying to access an account
I can't find what I'm looking for
Other issue not in this list
Submit
Thank you for your help!
You will not receive a reply. For enquiries,
contact us
.
Date modified:
2019-11-26
